Juniper Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Juniper Pharmaceuticals generated cash of $2,127,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,039,000 last year. Net change in cash is therefore $452,000.
Cash Flow
| 2013 | 7.07M | 315.09K | -89.06K |
|---|---|---|---|
| 2014 | 6.92M | -2.04M | -8.74M |
| 2015 | -891K | -1.70M | -206K |
| 2016 | 11.18M | -3.56M | -254K |
| 2017 | 2.12M | -2.84M | 1.03M |
JNP Cash Flow Statement (2013 – 2017)
| 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|
Cash at beginning of period | 20.99M | 13.90M | 16.76M | 20.71M | 13.20M |
Operating activities | |||||
Net income | -2.06M | 5.95M | -2.13M | 3.39M | 6.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.25M | 1.89M | 1.91M | 1.99M | 919.09K |
Stock-based compensation expense | 1.46M | 1.20M | 1.75M | 607K | 475.30K |
| Deferred income tax benefit | 1.46M | 1.20M | 1.75M | 607K | 475.30K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 2.17M | 192K | -2.49M | 1.70M | -2.34M |
Inventories | -704K | -1.99M | -424K | -619K | 46.47K |
Accounts payable | 183K | 1.58M | -925K | 91K | 314.75K |
Cash generated by operating activities | 2.12M | 11.18M | -891K | 6.92M | 7.07M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -2.84M | -3.56M | -1.70M | -2.04M | -522.35K |
Acquisitions Net | 0 | 0 | 0 | 0 | -14.51M |
Cash generated by investing activities | -2.84M | -3.56M | -1.70M | -2.04M | 315.09K |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -14K | -28K | -28K | -28K | -27.5K |
Repurchases of common stock | 0 | 0 | -22K | -8.50M | 0 |
Repayments of term debt | 1.05M | -226K | -238K | -245K | -72.27K |
Cash used in financing activities | 1.03M | -254K | -206K | -8.74M | -89.06K |
Net Change In Cash | 452K | 7.09M | -2.86M | -3.95M | 7.51M |
Cash at end of period | 21.44M | 20.99M | 13.90M | 16.76M | 20.71M |